Elena Maneschi

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function.

INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function.

Journal: The Journal of endocrinology

Published: May 16, 2018

Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.

Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.

Journal: The Journal of steroid biochemistry and molecular biology

Published: October 12, 2016

Differential Effects of Testosterone and Estradiol on Clitoral Function: An Experimental Study in Rats.

Differential Effects of Testosterone and Estradiol on Clitoral Function: An Experimental Study in Rats.

Journal: The journal of sexual medicine

Published: May 02, 2016

Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension.

Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension.

Journal: The Journal of steroid biochemistry and molecular biology

Published: February 08, 2016

Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits.

Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits.

Journal: Molecular and cellular endocrinology

Published: July 31, 2015

Metformin in vitro and in vivo increases adenosine signaling in rabbit corpora cavernosa.

Metformin in vitro and in vivo increases adenosine signaling in rabbit corpora cavernosa.

Journal: The journal of sexual medicine

Published: May 22, 2014

Tadalafil effect on metabolic syndrome-associated bladder alterations: an experimental study in a rabbit model.

Tadalafil effect on metabolic syndrome-associated bladder alterations: an experimental study in a rabbit model.

Journal: The journal of sexual medicine

Published: March 12, 2014

Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit.

Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit.

Journal: Molecular and cellular endocrinology

Published: November 08, 2013

FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS.

FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS.

Journal: The Journal of endocrinology

Published: June 11, 2013

Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits.

Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits.

Journal: Molecular and cellular endocrinology

Published: May 20, 2013

Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?

Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?

Journal: The Prostate

Published: March 06, 2013

PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.

PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.

Journal: The Prostate

Published: February 15, 2013

Showing 1-12 of 18

Last Updated: 09/26/2026